Abstract
BackgroundType I interferon (IFN) plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE) and dermatomyositis (DM)/polymyositis (PM) as typically evidenced by upregulation of type I IFN-stimulated genes...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have